News
Ascendis Pharma A/S (Nasdaq: ASND) today announced three oral presentations of its latest achondroplasia and hypoparathyroidism data at ASBMR 2025, the annual meeting of the American Society for Bone ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback